Huang, A. C. & Zappasodi, R. A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance. Nat. Immunol. 23, 660–670 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weber, J. et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N. Engl. J. Med. 377, 1824–1835 (2017).

Article  CAS  PubMed  Google Scholar 

Larkin, J. et al. Five-year survival with combined nivolumab and ipilimumab in advanced melanoma. N. Engl. J. Med. 381, 1535–1546 (2019).

Article  CAS  PubMed  Google Scholar 

Huang, A. C. et al. T-cell invigoration to tumour burden ratio associated with anti-PD-1 response. Nature 545, 60–65 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang, A. C. et al. A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma. Nat. Med. 25, 454–461 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fairfax, B. P. et al. Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma. Nat. Med. 26, 193–199 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miller, B. C. et al. Author correction: subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade. Nat. Immunol. 20, 1556 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sotomayor, E. M., Borrello, I., Tubb, E., Allison, J. P. & Levitsky, H. I. In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance. Proc. Natl Acad. Sci. USA 96, 11476–11481 (1999).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wei, S. C. et al. Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade. Cell 170, 1120–1133.e1117 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Das, R. et al. Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo. J Immunol 194, 950–959 (2015).

Article  CAS  PubMed  Google Scholar 

Franken, A. et al. CD4+ T cell activation distinguishes response to anti-PD-L1 + anti-CTLA4 therapy from anti-PD-L1 monotherapy. Immunity 57, 541–558.e547 (2024).

Article  CAS  PubMed  Google Scholar 

Codarri Deak, L. et al. PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells. Nature 610, 161–172 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hashimoto, M. et al. PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program. Nature 610, 173–181 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bengsch, B. et al. Epigenomic-guided mass cytometry profiling reveals disease-specific features of exhausted CD8 T cells. Immunity 48, 1029–1045.e1025 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chronister, W. D. et al. TCRMatch: predicting T-cell receptor specificity based on sequence similarity to previously characterized receptors. Front. Immunol. 12, 640725 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsui, C. et al. MYB orchestrates T cell exhaustion and response to checkpoint inhibition. Nature 609, 354–360 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083–1086 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

McLane, L. M. et al. Role of nuclear localization in the regulation and function of T-bet and Eomes in exhausted CD8 T cells. Cell Rep. 35, 109120 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seo, H. et al. TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion. Proc. Natl Acad. Sci. USA 116, 12410–12415 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ohl, K. et al. CREM alpha enhances IL-21 production in T cells in vivo and in vitro. Front. Immunol. 7, 618 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Hermans, D. et al. Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8+ T cell stemness and antitumor immunity. Proc. Natl Acad. Sci. USA 117, 6047–6055 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leonard, W. J. & Wan, C. K. IL-21 Signaling in Immunity. F1000Res 5, F1000 (2016).

Tian, Y. et al. A context-dependent role for IL-21 in modulating the differentiation, distribution, and abundance of effector and memory CD8 T cell subsets. J. Immunol. 196, 2153–2166 (2016).

Article  CAS  PubMed  Google Scholar 

Cui, W., Liu, Y., Weinstein, J. S., Craft, J. & Kaech, S. M. An interleukin-21-interleukin-10–STAT3 pathway is critical for functional maturation of memory CD8+ T cells. Immunity 35, 792–805 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mastroianni, J. et al. miR-146a controls immune response in the melanoma microenvironment. Cancer Res. 79, 183–195 (2019).

Article  CAS  PubMed  Google Scholar 

Curran, M. A., Montalvo, W., Yagita, H. & Allison, J. P. PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proc. Natl Acad. Sci. USA 107, 4275–4280 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gangaev, A. et al. Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response. Proc. Natl Acad. Sci. USA 118, e2102849118 (2021).

Gros, A. et al. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients. Nat. Med. 22, 433–438 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yossef, R. et al. Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancers. Cancer Cell 41, 2154–2165.e2155 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spitzer, M. H. et al. Systemic immunity is required for effective cancer immunotherapy. Cell 168, 487–502.e415 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zander, R. et al. CD4+ T cell help is required for the formation of a cytolytic CD8+ T cell subset that protects agai